“AYA Cancer Chat: Life Interrupted” is an insightful, CHOP-produced podcast where adolescents and young adults discuss their experience with cancer, with the goal of helping current patients.

A collaborative effort transformed the proton therapy facility into colorful rooms with unique themes and helped replace patients’ anxiety with anticipation.

Anna T. Meadows, MD, a pediatric oncologist who led the way for survivorship studies of children with cancer reflects on her 40-year career at Children’s Hospital of Philadelphia.

After four years of battling leukemia, Mitch was no longer responding to his cancer therapy. But new immunotherapy options at Children's Hospital gave him another chance to be a kid.

Members of the CHOP Cancer Center team work to ensure that our patients’ and families’ transition to outpatient care is smooth and successful.

The Psychosocial Services Program in the Division of Oncology at Children’s Hospital of Philadelphia provides comprehensive psychosocial services for children with cancer and members of their families.

CHOP recently launched a Bone and Soft Tissue Tumor Program, a collaboration between teams from Orthopedics and Oncology.

CHOP's revolutionary T-cell immunotherapy was featured at “Cellular Horizons: The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact,” an exclusive international event at the Vatican.

The Children’s Oncology Group (COG) high risk acute lymphoblastic leukemia (HR ALL) TARGET Project is a large collaborative effort led by Stephen Hunger, MD.

CHOP is working to improve personalized cell therapy for children. Using younger T cells may offer better results against certain types of leukemia and lymphoma.